亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Gut microbiota: A key modulator of individualized efficacy and toxicity in cancer therapy

作者
Xiaoying Hou,Kailing Chen,Lingsi Ran,Rui Pu,Rouming Tong,Pan Li,Kan Liu,Hongzhi Du,Yuchen Liu,Xiaoying Hou
出处
期刊:Journal of Pharmaceutical Analysis [Elsevier BV]
卷期号:: 101802-101802
标识
DOI:10.1016/j.jpha.2026.101802
摘要

Inherent heterogeneity in response to cancer therapy remains a major clinical challenge. The composition and function of the gut microbiota are regulated by multiple factors, and its heterogeneity is a key determinant of individualized variability in therapeutic response. Accordingly, microbiota-targeted interventions combined with conventional therapies have emerged as a promising strategy for precision cancer treatment. However, comprehensive and systematic studies summarizing gut microbiota-mediated individualized response of anti-cancer therapies remain limited. To summarize current advances, we searched PubMed, Web of Science, Embase and ClinicalTrials using different combinations of keywords “gut microbiota”, “pharmacomicrobiomics”, “cancer therapy” and “personalized therapy” for studies published from January 1985 to June 2026. The available evidence shows that the gut microbiota profoundly influences tumorigenesis, cancer progression and therapeutic responses in a microbial taxon-, cancer type-, and treatment- specific manner. Specific microbial signatures may serve as predictive biomarkers for identifying patients with differential sensitivity to anticancer therapy. Moreover, gut microbiota-based interventions, when combined with standard treatments, hold considerable potential for improving therapeutic outcomes, although their clinical application remains largely exploratory. Emerging evidence also highlights important roles for intratumoral bacteria, enteroviruses and fungi in tumor progression and treatment response, providing additional opportunities for therapeutic optimization. Finally, we discuss the major limitations of current preclinical and clinical studies and outline future directions, including the integration of spatial omics technologies, large-scale randomized controlled trials and artificial intelligence assisted analyses. Collectively, this review provides a comprehensive framework for microbiota-guided precision oncology and highlights its potential to improve therapeutic efficacy and patient outcomes.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
优美的豪英完成签到,获得积分10
2秒前
科研通AI65的应助被晚风采纳,获得10
10秒前
16秒前
17秒前
leo发布了新的文献求助10
21秒前
34秒前
风一样的风干肠完成签到 ,获得积分10
35秒前
39秒前
yqt完成签到,获得积分10
41秒前
41秒前
41秒前
42秒前
fantasy的应助被科研通管家采纳,获得10
42秒前
42秒前
42秒前
晚风发布了新的文献求助10
46秒前
50秒前
xin完成签到,获得积分10
54秒前
Owen的应助被leo采纳,获得10
55秒前
你奶奶完成签到,获得积分10
57秒前
丘比特的应助被你奶奶采纳,获得10
1分钟前
Owen的应助被诚心的茉莉采纳,获得10
1分钟前
orixero的应助被白华苍松采纳,获得10
1分钟前
1分钟前
仁爱的鹤轩完成签到,获得积分10
1分钟前
leo发布了新的文献求助10
1分钟前
小王快毕业完成签到,获得积分20
1分钟前
CodeCraft的应助被leo采纳,获得10
1分钟前
晚风发布了新的文献求助10
1分钟前
JY发布了新的文献求助10
1分钟前
1分钟前
今后的应助被林林采纳,获得10
1分钟前
机灵的以莲完成签到,获得积分10
1分钟前
yc发布了新的文献求助10
1分钟前
1分钟前
leo发布了新的文献求助10
1分钟前
wanci的应助被leo采纳,获得10
2分钟前
半山听雨N完成签到 ,获得积分10
2分钟前
LL发布了新的文献求助10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190078
求助须知:如何正确求助?哪些是违规求助? 9577216
关于积分的说明 21852047
捐赠科研通 7788239
什么是DOI,文献DOI怎么找? 3436240
关于科研通互助平台的介绍 2559964
邀请新用户注册赠送积分活动 2482824